tiprankstipranks
Vicarious Surgical Inc. (RBOT)
:RBOT
US Market

Vicarious Surgical (RBOT) Earnings Dates, Call Summary & Reports

Compare
224 Followers

Earnings Data

Report Date
May 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-2.48
Last Year’s EPS
-2.7
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 17, 2025
|
% Change Since: -26.17%
|
Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments and challenges. While the company made significant strides in system integration, partnership expansions, and cost management, they also faced supply chain issues that have delayed clinical trials. The sentiment is balanced with strong achievements countered by notable delays.
Company Guidance
During Vicarious Surgical's 2024 fourth quarter and full year earnings call, several key metrics and guidance were highlighted. The company reported total operating expenses for the full year at $66.6 million, down 17% year-over-year. Research and development expenses were $40.2 million, general and administrative expenses totaled $21.9 million, and sales and marketing expenses were $4.5 million. The adjusted net loss for 2024 was $63.3 million, equating to an adjusted net loss of $10.75 per share. Vicarious Surgical's cash burn rate for 2024 was $49 million, resulting in a year-end balance of $49 million in cash, cash equivalents, and short-term investments. Looking ahead, the company anticipates a cash burn of approximately $50 million in 2025, with plans to reinforce the balance sheet strategically. Additionally, their first clinical human trials are expected to commence closer to the end of the year, with a de novo submission anticipated for late 2026.
Successful Completion of Version 1.0 System Integration
The company successfully completed the integration of its Version 1.0 system, demonstrating functionality and performance in a cadaveric preclinical setting, marking a significant step forward in bringing their robotic surgery platform to market.
Expansion of Hospital System Partnerships
Vicarious Surgical announced agreements with several major academic health institutions such as LSU Health New Orleans, Temple Health, and University of Illinois Health, which will aid in developing medical education and training protocols.
Reduced Operating Expenses
Total operating expenses for full year 2024 were reduced by 17% year-over-year, with R&D expenses down from $47.6 million in 2023 to $40.2 million in 2024.
Strong Cash Management
The company reported a cash burn rate of $49 million, achieving a favorable variance from the original guidance of $50 million, ending the year with approximately $49 million in cash, cash equivalents, and short-term investments.
---

Vicarious Surgical (RBOT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RBOT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 12, 20252025 (Q1)
-2.48 / -
-2.7
Mar 17, 20252024 (Q4)
-2.69 / -2.43
-2.1-15.71% (-0.33)
Nov 12, 20242024 (Q3)
-2.58 / -2.88
-3.620.08% (+0.72)
Aug 12, 20242024 (Q2)
-2.72 / -2.86
-4.840.42% (+1.94)
Apr 29, 20242024 (Q1)
-2.85 / -2.70
-5.147.06% (+2.40)
Mar 04, 20242023 (Q4)
-3.75 / -2.10
-4.856.25% (+2.70)
Nov 13, 20232023 (Q3)
-4.21 / -3.60
-5.433.33% (+1.80)
Jul 27, 20232023 (Q2)
-4.28 / -4.80
-4.80.00% (0.00)
May 08, 20232023 (Q1)
-4.05 / -5.10
-4.5-13.33% (-0.60)
Feb 13, 20232022 (Q4)
-5.28 / -4.80
-4.5-6.67% (-0.30)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

RBOT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 17, 2025$9.63$8.20-14.85%
Nov 12, 2024$11.14$9.15-17.86%
Aug 12, 2024$5.50$5.21-5.27%
Apr 29, 2024$8.40$8.42+0.24%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Vicarious Surgical Inc. (RBOT) report earnings?
Vicarious Surgical Inc. (RBOT) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
    What is Vicarious Surgical Inc. (RBOT) earnings time?
    Vicarious Surgical Inc. (RBOT) earnings time is at May 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RBOT EPS forecast?
          RBOT EPS forecast for the fiscal quarter 2025 (Q1) is -2.48.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis